Study identifier:D1843R00359
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Prospective observational multicenter study of patients with Arterial hypertension and chronic kidney disease markers in Kazakhstan (PROGRESS-CKD)
To describe the rate of CKD diagnosis in patients with hypertension and CKD markers
N/A
No
-
All
1282
Observational
18 Years - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Dec 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
- |